MEI Pharma Inc. Watch

from 10-Q 9 pages Consulting Services Agreement Amended September 13, 2024

from 10-Q 9 pages Consulting Services Agreement Amended September 13, 2024

from 10-Q 12 pages Separation and Release Agreement

from 10-Q 12 pages Separation and Release Agreement

from 10-K 4 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential

from 10-Q 21 pages MEI Pharma, Inc. Amended and Restated 2008 Stock Omnibus Equity Compensation Plan Effective as of December 18, 2023

from 10-Q 13 pages Material contract

from 8-K 30 pages Cooperation Agreement

from 10-K 15 pages Form of Warrant

from 8-K 8 pages Separation and Release Agreement

from 8-K 2 pages Via Email and Hand Delivery Infinity Pharmaceuticals, Inc. 1100 Massachusetts Avenue, Floor 4 Cambridge, Massachusetts 02138 Attention: General Counsel Email: SETH.TASKER@INFI.com Re: Termination Notice Dear Seth

from 8-K 15 pages Termination Agreement

from 8-K 18 pages MEI Pharma, Inc. Amended & Restated 2021 Inducement Grant Equity Compensation Plan

from 8-K 27 pages June 9, 2023 Dear Jay,

from 8-K 7 pages MEI Pharma, Inc. Employee Proprietary Information and Inventions Agreement

from S-4/A 8 pages This Is an Important Legal Document. Please Confer With a Lawyer or Other Trusted Advisor Before Signing This Document

from S-4/A 3 pages As You Know, Infinity Pharmaceuticals, Inc. (“Infinity”) Is Entering Into a Merger Agreement With MEI Pharma, Inc. (“Mei”) by Which, if the Merger Is Completed in Accordance With Its Terms, Infinity Will Become a Subsidiary of MEI. References to “Infinity” Below Include MEI if and After the Merger Closes. We Recognize That Your Contributions to Infinity in the Past Have Been Integral to Its Success and That Your Continued Involvement With and After the Merger Will Be Necessary to Facilitate the Completion of the Merger and Are Critical to Ensuring the Success of the Merged Company. to Incentivize You to Remain With Infinity Through June 30, 2023 (The “Payment Date”), You Will Be Eligible to Receive the Payment Described in This Agreement (The “Agreement”)

from S-4/A 3 pages As You Know, Infinity Pharmaceuticals, Inc. (“Infinity”) Is Entering Into a Merger Agreement With MEI Pharma, Inc. (“Mei”) by Which, if the Merger Is Completed in Accordance With Its Terms, Infinity Will Become a Subsidiary of MEI. References to “Infinity” Below Include MEI if and After the Merger Closes. We Recognize That Your Contributions to Infinity in the Past Have Been Integral to Its Success and That Your Continued Involvement With and After the Merger Will Be Necessary to Facilitate the Completion of the Merger and Are Critical to Ensuring the Success of the Merged Company. to Incentivize You to Remain With Infinity Through the Closing of the Merger (The “Closing”), You Will Be Eligible to Receive the Payment Described in This Agreement (The “Agreement”)

from S-4/A 3 pages (2) Your Employment Is and Will Be At-Will. You Understand That Infinity Retains the Right to Terminate Your Services With or Without Cause and You Retain the Right to Terminate Your Services for Infinity at Any Time. for the Purposes of This Agreement and the Application of the Term Elsewhere in This Agreement, “Cause” Shall Have the Meaning Set Forth in the Infinity Executive Severance Benefits Plan as in Effect on the Date of This Agreement and Without Regard to Any Future Amendments Thereto (The “Severance Plan”), but With Clause (I) of Such “Cause” Definition Replaced With “A Good Faith Finding by the Board of Directors of the Company or Its Public Parent Corporation of a Knowing and Willful Failure by the Employee to Perform the Employee’s Material Duties for the Company in a Manner Reasonably Acceptable to the Company, Which Failure Continues for a Period of More Than 30 Days After Notice Thereof Has Been Provided to the Employee in Writing by the Company, Setting Forth in Reasonable Detail the Nature of Such Failure.”

from S-4/A 3 pages (2) Your Employment Is and Will Be At-Will. You Understand That Infinity Retains the Right to Terminate Your Services With or Without Cause and You Retain the Right to Terminate Your Services for Infinity at Any Time. for the Purposes of This Agreement and the Application of the Term Elsewhere in This Agreement, “Cause” Shall Have the Meaning Set Forth in the Infinity Executive Severance Benefits Plan as in Effect on the Date of This Agreement and Without Regard to Any Future Amendments Thereto (The “Severance Plan”), but With Clause (I) of Such “Cause” Definition Replaced With “A Good Faith Finding by the Board of Directors of the Company or Its Public Parent Corporation of a Knowing and Willful Failure by the Employee to Perform the Employee’s Material Duties for the Company in a Manner Reasonably Acceptable to the Company, Which Failure Continues for a Period of More Than 30 Days After Notice Thereof Has Been Provided to the Employee in Writing by the Company, Setting Forth in Reasonable Detail the Nature of Such Failure.”